Barenholz Y - Search Results

1

Characterization of Pegylated Liposomal Mitomycin C Lipid-Based Prodrug (Promitil) by High Sensitivity Differential Scanning Calorimetry and Cryogenic Transmission Electron Microscopy.

Wei X, Patil Y, Ohana P, Amitay Y, Shmeeda H, Gabizon A, Barenholz Y. Wei X, et al. Among authors: barenholz y. Mol Pharm. 2017 Dec 4;14(12):4339-4345. doi: 10.1021/acs.molpharmaceut.6b00865. Epub 2017 Oct 30. Mol Pharm. 2017. PMID: 28045540

2

Insights into composition/structure/function relationships of Doxil® gained from "high-sensitivity" differential scanning calorimetry.

Wei X, Cohen R, Barenholz Y. Wei X, et al. Among authors: barenholz y. Eur J Pharm Biopharm. 2016 Jul;104:260-70. doi: 10.1016/j.ejpb.2016.04.011. Epub 2016 Apr 19. Eur J Pharm Biopharm. 2016. PMID: 27106607

3

Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer.

Shmeeda H, Amitay Y, Gorin J, Tzemach D, Mak L, Stern ST, Barenholz Y, Gabizon A. Shmeeda H, et al. Among authors: barenholz y. J Drug Target. 2016 Nov;24(9):878-889. doi: 10.1080/1061186X.2016.1191081. Epub 2016 Jun 6. J Drug Target. 2016. PMID: 27187807

4

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies.

Gabizon A, Shmeeda H, Barenholz Y. Gabizon A, et al. Among authors: barenholz y. Clin Pharmacokinet. 2003;42(5):419-36. doi: 10.2165/00003088-200342050-00002. Clin Pharmacokinet. 2003. PMID: 12739982 Review.

5

Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs.

Gabizon AA, Barenholz Y, Bialer M. Gabizon AA, et al. Among authors: barenholz y. Pharm Res. 1993 May;10(5):703-8. doi: 10.1023/a:1018907715905. Pharm Res. 1993. PMID: 8321835

6

Using solution X-ray scattering to determine the high-resolution structure and morphology of PEGylated liposomal doxorubicin nanodrugs.

Schilt Y, Berman T, Wei X, Barenholz Y, Raviv U. Schilt Y, et al. Among authors: barenholz y. Biochim Biophys Acta. 2016 Jan;1860(1 Pt A):108-19. doi: 10.1016/j.bbagen.2015.09.012. Epub 2015 Sep 21. Biochim Biophys Acta. 2016. PMID: 26391840

7

Optimization and upscaling of doxorubicin-containing liposomes for clinical use.

Amselem S, Gabizon A, Barenholz Y. Amselem S, et al. Among authors: barenholz y. J Pharm Sci. 1990 Dec;79(12):1045-52. doi: 10.1002/jps.2600791202. J Pharm Sci. 1990. PMID: 2079648

8

In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release.

Horowitz AT, Barenholz Y, Gabizon AA. Horowitz AT, et al. Among authors: barenholz y. Biochim Biophys Acta. 1992 Aug 24;1109(2):203-9. doi: 10.1016/0005-2736(92)90084-y. Biochim Biophys Acta. 1992. PMID: 1520697

9

The influence of physical characteristics of liposomes containing doxorubicin on their pharmacological behavior.

Goren D, Gabizon A, Barenholz Y. Goren D, et al. Among authors: barenholz y. Biochim Biophys Acta. 1990 Nov 16;1029(2):285-94. doi: 10.1016/0005-2736(90)90165-k. Biochim Biophys Acta. 1990. PMID: 2245212

10

Effect of the ammonium salt anion on the structure of doxorubicin complex and PEGylated liposomal doxorubicin nanodrugs.

Schilt Y, Berman T, Wei X, Nativ-Roth E, Barenholz Y, Raviv U. Schilt Y, et al. Among authors: barenholz y. Biochim Biophys Acta Gen Subj. 2021 May;1865(5):129849. doi: 10.1016/j.bbagen.2021.129849. Epub 2021 Jan 15. Biochim Biophys Acta Gen Subj. 2021. PMID: 33460771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters